The Bionic Power Agilik Smart Orthosis

Interested in learning more about how Agilik can support your patients? Please contact Curt Bertram at cbertram@spsco.com.

The Bionic Power Agilik Smart Orthosis

Contact Curt Bertram at cbertram@spsco.com to initiate the required training. Once you've successfully completed the courses, an ordering link will be provided. Click here to view all post‑training support materials.

The Bionic Power Agilik smart orthosis is the first powered microprocessor-controlled knee-ankle-foot orthosis (MPKAFO) designed for adult and pediatric patients with neurological and musculoskeletal gait impairments affecting mobility and function. Backed by an IRB-approved clinical study and published outcomes, the Agilik boosts endurance and mobility with smart, real-time knee extension and flexion. Available through SPS, the Agilik comes with full clinical training and optional consulting services—helping you deliver proven results with confidence.

LEARN MORE

Features and Benefits:

• Non-invasive mobility solution
• Customizable for each patient’s changing condition and their growth
• Proven wearable technology
• Smart system: real-time gait detection drives assistance for flexion and extension
• Flexible, personalized design for assisting anyone 5 years old and older
• For clinic, at home, and community mobility
• Mobile app to initiate Activities of Daily Living modes

Who Can Benefit?

• Patients with neuromuscular or musculoskeletal gait impairments, such as stroke, cerebral palsy, or spina bifida
• Patients with crouch gait or lower-limb instability
• Ambulatory individuals with knee-extension deficiency disorders whose strength and endurance deteriorate with age

Clinical Indications:

• Knee-extension deficiency due to neuromuscular conditions
• Progressive crouch gait or fatigue with distance walking
• Quadriceps/hamstring weakness causing stance-phase instability
• Sagittal plane knee instability in ambulatory patients
• Compensatory gait strategies linked to trunk or hip overuse
• Functional decline from fatigue limiting mobility
• Need for high-repetition gait training to support neuroplasticity

Outcomes:

The Hanger Institute for Clinical Research & Education conducted a prospective study on the Agilik™ externally powered pediatric MPKAFO over three months following structured in‑clinic training.

Sixteen children ages 6–16 with flexed‑knee gait were enrolled; 13 completed the study.

Key Outcomes Include:

• Improved gait quality (higher Observational Gait Scale scores)
• Statistically significant gains in health‑related quality of life (EQ‑5D‑Y‑3L)
• Parent‑reported improvements such as fewer trips, falls, and foot drag
• No significant changes in performance‑based walking measures, suggesting an early adaptation period

These results add to growing evidence that powered MPKAFOs like the Agilik may benefit pediatric users with flexed‑knee gait in real‑world settings. Click here to read more.